HRAS and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, KRAS mutations dominate (~90–95%), especially at codon 12 (G12D, G12V, G12R), while NRAS and HRAS mutations are essentially absent [18].